Results 121 to 130 of about 299,195 (309)

Post‐Exposure Hepatitis B‐Treatment in Newborns: A Qualitative Study on Interprofessional Practices in Norway

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim Children born to mothers with chronic Hepatitis B virus (HBV) infection are at substantial risk of developing chronic HBV‐infection without appropriate perinatal post‐exposure treatment. This study aimed to explore midwives' and public health nurses' (PHNs) experiences with HBV‐post‐exposure treatment for infants and identify factors ...
Brita Askeland Winje   +4 more
wiley   +1 more source

Review of Rabies Preventions and Control [PDF]

open access: yes, 2017
Rabies is an acute viral infection of the central nervous system, caused by a lyssavirus in the family Rhabdoviridae. It is zoonotic viral disease that can affect all mammals, including humans, cats, dogs, and wildlife and farm animals.
Abdela, N. (Nejash)   +1 more
core   +2 more sources

Rationale for Recommending Varicella Vaccination Into the Swedish National Immunisation Programme

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim Under Swedish law, a vaccination may be included in the National Immunisation Programme (NIP) if it effectively prevents transmission in the population, is cost‐effective and aligns with ethical and humanitarian principles. The Public Health Agency of Sweden (PHAS) evaluated these criteria for introducing varicella vaccination. Methods The
Annika Ersson   +2 more
wiley   +1 more source

Prevalence of viral and non-viral hepatitis in Menoua Division, West Region, Cameroon: a retrospective hospital-based study

open access: yesThe Pan African Medical Journal, 2019
INTRODUCTION: The paucity of data on hepatitis' epidemiology in Menoua Division, West Region, Cameroon, prompted us to assess the prevalence of viral and non-viral hepatitis in this area.
Mathias Kenfack Tsague   +5 more
doaj   +1 more source

Predicting the effectiveness of hepatitis C virus neutralizing antibodies by bioinformatic analysis of conserved epitope residues using public sequence data [PDF]

open access: yes, 2018
Hepatitis C virus (HCV) is a global health issue. Although direct-acting antivirals are available to target HCV, there is currently no vaccine. The diversity of the virus is a major obstacle to HCV vaccine development. One approach toward a vaccine is to
Cowton, Vanessa M.   +3 more
core   +2 more sources

A Personalised Vaccination Program Based on Immune Reconstitution in Paediatric Cancer Survivors

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aims Paediatric cancer survivors often experience treatment‐induced immunosuppression, requiring post‐treatment revaccination. However, immune recovery timelines vary, and current revaccination guidelines, largely based on data of varied quality derived from studies on acute‐lymphoblastic‐leukaemia (ALL), may not be applicable across all ...
Menucha Jurkowicz   +17 more
wiley   +1 more source

Hepatitis B Virus Infection: A Mini Review

open access: yesViruses
Hepatitis B and C viruses (HBV and HCV) are the leading causes of end-stage liver disease worldwide. Although there is a potent vaccine against HBV, many new infections are recorded annually, especially in poorly resourced places which have lax ...
D. Asandem   +3 more
semanticscholar   +1 more source

Diagnostic Impact of Liver Biopsy Among Antinuclear Antibody Positive Individuals With Mild Liver Enzyme Elevation

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
In ANA‐positive patients with suspected autoimmune hepatitis (AIH), liver biopsy rarely altered therapeutic management when alanine aminotransferase (ALT) was below 101 U/L and cirrhosis was absent. These findings suggest that biopsy may be safely deferred in this low‐risk group.
David Mehdi Asgher Niazi   +8 more
wiley   +1 more source

Interferons and hepatitis C virus

open access: yesSwiss Medical Weekly, 2012
Interferons are not only the first line of defence against viral infections such as hepatitis C virus infections, but they also have important roles during the chronic phase of viral infections.
Markus H. Heim
doaj   +1 more source

Assessing Risk Thresholds in Controlled Human Infection Models (CHIM)

open access: yesBioethics, EarlyView.
ABSTRACT Controlled Human Infection Models (CHIMs) are a type of clinical trial involving deliberately exposing human volunteers to an infectious agent. Compared to studies of natural infection, CHIMs offers distinctive benefits, from the ability to study presymptomatic infection to a direct assessment of the efficacy of vaccines and therapeutics in a ...
Alexa Nord‐Bronzyk   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy